我們已在上線! 進一步了解
BDSI

BioDelivery Sciences International, Inc.

已下市

BDSI已於2022年3月22日下市。

 

關於: BioDelivery Sciences International Inc is a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic pain. The company is utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA) technology and other drug delivery technologies to develop and commercialize, either on its own or in partnership with third parties, new applications of therapies aimed at addressing important unmet medical needs. Its products include Belbuca and Symproic.

員工: 176

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%

我們尚未收到任何關於BDSI的最新新聞文章。

價格圖表採用Lightweight Charts™實作